Quipt Home Medical (QIPT)
(Delayed Data from NSDQ)
$3.66 USD
0.00 (0.00%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.66 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Income Statements
Fiscal Year end for Quipt Home Medical Corp falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 222 | 140 | 102 | 73 | 61 |
Cost Of Goods | 62 | 33 | 28 | 20 | 18 |
Gross Profit | 160 | 107 | 74 | 53 | 43 |
Selling & Adminstrative & Depr. & Amort Expenses | 156 | 102 | 76 | 52 | 46 |
Income After Depreciation & Amortization | 4 | 5 | -1 | 1 | -3 |
Non-Operating Income | 0 | 0 | -6 | -3 | -3 |
Interest Expense | 7 | 2 | 2 | 2 | 2 |
Pretax Income | -3 | 3 | -9 | -4 | -7 |
Income Taxes | 0 | -2 | -3 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -3 | 5 | -6 | -4 | -7 |
Extras & Discontinued Operations | 0 | 0 | 0 | -1 | 1 |
Net Income (GAAP) | -3 | 5 | -6 | -5 | -6 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 44 | 28 | 16 | 15 | 8 |
Depreciation & Amortization (Cash Flow) | 40 | 23 | 18 | 15 | 11 |
Income After Depreciation & Amortization | 4 | 5 | -1 | 1 | -3 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 39.77 | 37.22 | 30.44 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.07 | 0.13 | 0.08 | NA | NA |
Diluted Net EPS (GAAP) | -0.07 | 0.13 | -0.20 | -0.06 | -0.07 |
Fiscal Year end for Quipt Home Medical Corp falls in the month of September.
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 65.36 | 62.52 | 60.28 | 58.12 |
Cost Of Goods | NA | 17.90 | 20.45 | 16.63 | 14.91 |
Gross Profit | NA | 47.47 | 42.07 | 43.65 | 43.21 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 46.10 | 41.01 | 43.49 | 41.90 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.37 | 1.06 | 0.16 | 1.31 |
Non-Operating Income | NA | 0.22 | -0.32 | 0.44 | -0.04 |
Interest Expense | NA | 1.96 | 1.90 | 1.97 | 2.02 |
Pretax Income | NA | -0.37 | -1.25 | -1.36 | -0.75 |
Income Taxes | NA | 0.22 | 0.08 | -0.32 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.59 | -1.33 | -1.03 | -0.75 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -0.59 | -1.33 | -1.03 | -0.75 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 39.31 | 44.20 | 40.58 | 35.86 |
Diluted EPS Before Non-Recurring Items | NA | -0.01 | -0.03 | -0.03 | -0.02 |
Diluted Net EPS (GAAP) | NA | -0.01 | -0.03 | -0.03 | -0.02 |